• RM576 Save up to RM288 with the Yearly Premium Plan (Limited Time Only)
  • RM480 Save up to RM240 with the Yearly Advanced Plan (Limited Time Only)
Subscribe Now
premium Subscription Plan
add free StockBiz
YouTube MS Production

Last Price Change Volume
KLSE Market Watch
Open: Day Range: Prev Close:


OTHERS SUPPLY AGREEMENT BETWEEN A SUBSIDIARY OF THE RUSSIAN DIRECT INVESTMENT FUND (RDIF) AND DUOPHARMA (M) SENDIRIAN BERHAD (DMSB), A WHOLLY OWNED SUBSIDIARY OF DUOPHARMA BIOTECH BERHAD, FOR THE DISTRIBUTION OF THE SPUTNIK V VACCINE (VACCINE) IN MALAYSIA

DUOPHARMA BIOTECH BERHAD

Type Announcement
Subject OTHERS
Description
SUPPLY AGREEMENT BETWEEN A SUBSIDIARY OF THE RUSSIAN DIRECT INVESTMENT FUND (RDIF) AND DUOPHARMA (M) SENDIRIAN BERHAD (DMSB), A WHOLLY OWNED SUBSIDIARY OF DUOPHARMA BIOTECH BERHAD, FOR THE DISTRIBUTION OF THE SPUTNIK V VACCINE (VACCINE) IN MALAYSIA

We refer to the announcements made on 26 January 2021, 25 February 2021, 11 March 2021, 1 April 2021, 9 April 2021, 30 April 2021, 1 June 2021, 1 September 2021 and 24 November 2021 in relation to the supply agreement dated 12 May 2021 made between a subsidiary of the RDIF (the “Seller”) and DMSB (the “Seller Supply Agreement”) (“Announcements”). For consistency purposes, the abbreviations used in this announcement are the same as those previously defined in the Announcements unless otherwise defined herein.

 

As highlighted in the announcement made on 24 November 2021, the remaining condition precedent under the Seller Supply Agreement (namely the requirement that the Vaccine be approved by the DCA through technical evaluation by the NPRA) has not been fulfilled on or before the Cut-Off date that expired on 23 November 2021. As such, under the terms and conditions of the Seller Supply Agreement, either party thereto may terminate the said agreement by notice in writing to the other party.

 

The Board of Directors of Duopharma Biotech Berhad (“Duopharma Biotech”) wishes to announce that DMSB has by letter dated 24 March 2023 terminated the Seller Supply Agreement with effect from the date of the said letter.

 

The Seller Supply Agreement is in the ordinary course of business of the Duopharma Biotech Group.

 

This announcement is dated 24 March 2023.






Announcement Info

Company Name DUOPHARMA BIOTECH BERHAD
Stock Name DPHARMA
Date Announced 24 Mar 2023
Category General Announcement for PLC
Reference Number GA1-23032023-00018



Close
New Feature
MS Academy
AI StockMaster. Beat The Market! Checking MS Signal
DETECT REAL-TIME STOCK MOVEMENT
X
(InvestorPro Plan Only)
Complimentary access on Premium Plan*
What is AI StockMaster?
Window Alert On-Screen Alert X
X